Literature DB >> 11113689

Prognostic factors in Brazilian diabetic patients starting dialysis: a 3.6-year follow-up study.

R M Bruno1, J L Gross.   

Abstract

The objective of this study was to analyze the prognostic factors of a cohort of diabetic patients starting dialysis. This prospective, 3. 6-year population-based cohort study included 111 diabetic patients starting dialysis in all 18 dialysis centers of the metropolitan area of Porto Alegre, Brazil, between July 1995 and October 1996. The survival rate was analyzed by Kaplan-Meier curves and prognostic factors for death by Cox's proportional-hazards model. During the study period, 685 patients started dialysis; 182 (26.5%) had diabetes and 111 patients were included. Eighty-four percent of the 111 patients were classified as type 2 diabetes (random C-peptide>0. 6 ng/ml), and these patients presented more coronary artery disease (60% vs. 29%; P<0.02) than type 1 patients. In type 2 patients, later diagnosis of diabetes was associated with a shorter interval until beginning of dialysis (r=0.67; P=0.001). Diabetic nephropathy was the primary renal disease in 61% of all patients. Overall median survival (26 months) was similar for types 1 and 2 diabetic patients. Survival in the first, second, and third year was 69%, 51%, and 28%, respectively. Cardiovascular disease was the most common cause (63%) of death. According to Cox's proportional-hazards model, history of stroke (HR: 4.53, CI: 2.09-9.86, P<0.0001), amputations (HR: 3.2, CI: 1.61-6.35, P<0.0009), and coronary artery disease (HR: 1.67, CI: 0.95-2.96, P<0.076) at baseline were significantly associated with mortality. In conclusion, macrovascular complications were the main predictors of mortality in this cohort of diabetic patients starting dialysis. Intensive treatment of cardiovascular risk factors during dialysis might reduce the mortality rate of diabetic patients.

Entities:  

Mesh:

Year:  2000        PMID: 11113689     DOI: 10.1016/s1056-8727(00)00118-5

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  6 in total

Review 1.  FRMD3 gene: its role in diabetic kidney disease. A narrative review.

Authors:  Marjoriê Piuco Buffon; Denise Alves Sortica; Fernando Gerchman; Daisy Crispim; Luís Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2015-12-30       Impact factor: 3.320

Review 2.  The role of progranulin in diabetes and kidney disease.

Authors:  Bruna Bellincanta Nicoletto; Luis Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2015-12-21       Impact factor: 3.320

3.  rs1888747 polymorphism in the FRMD3 gene, gene and protein expression: role in diabetic kidney disease.

Authors:  Marjoriê P Buffon; Mariana P Carpena; Denise A Sortica; Andressa Santer; Rodrigo Carlessi; Bianca M de Souza; Maria I Edelweiss; Milton Berger; Daisy Crispim; Luís H Canani
Journal:  Diabetol Metab Syndr       Date:  2016-01-08       Impact factor: 3.320

4.  The Prevalence of Nondiabetic Renal Diseases in Patients with Diabetes Mellitus in the University Hospital of Ribeirão Preto, São Paulo.

Authors:  Diego Agra Souza; Gyl Eanes Barros Silva; Igor Lima Fernandes; Dyego José Araújo de Brito; Monique Pereira Rêgo Muniz; Osvaldo Merege Vieira Neto; Roberto Silva Costa; Márcio Dantas; Miguel Moyses Neto
Journal:  J Diabetes Res       Date:  2020-06-13       Impact factor: 4.011

5.  Diabetic nephropathy.

Authors:  Themis Zelmanovitz; Fernando Gerchman; Amely Ps Balthazar; Fúlvio Cs Thomazelli; Jorge D Matos; Luís H Canani
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

Review 6.  Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review.

Authors:  Andréa D Bertoldi; Panos Kanavos; Giovanny V A França; André Carraro; Cesar Augusto Ovieda Tejada; Pedro C Hallal; Alessandra Ferrario; Maria Inês Schmidt
Journal:  Global Health       Date:  2013-12-03       Impact factor: 4.185

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.